Literature DB >> 28199803

T-Cell Transfer Therapy Targeting Mutant KRAS.

Steven A Rosenberg1,2, Eric Tran1, Paul F Robbins1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28199803      PMCID： PMC6697099     

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  RAS Proteins and Their Regulators in Human Disease.

Authors:  Dhirendra K Simanshu; Dwight V Nissley; Frank McCormick
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

Review 2.  Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer.

Authors:  Nathan Singh; Junwei Shi; Carl H June; Marco Ruella
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

Review 3.  Kras and Tumor Immunity: Friend or Foe?

Authors:  Jane Cullis; Shipra Das; Dafna Bar-Sagi
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

4.  POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction.

Authors:  Qingqing Meng; Yahong Wu; Xinghua Sui; Jingjie Meng; Tingting Wang; Yan Lin; Zhiwei Wang; Xiuman Zhou; Yuanming Qi; Jiangfeng Du; Yanfeng Gao
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

Review 5.  Current Status of Immunotherapies for Treating Pancreatic Cancer.

Authors:  Annie A Wu; Elizabeth Jaffee; Valerie Lee
Journal:  Curr Oncol Rep       Date:  2019-05-17       Impact factor: 5.945

6.  Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions.

Authors:  Asaf Maoz; Carter Merenstein; Yusuke Koga; Austin Potter; Adam C Gower; Gang Liu; Sherry Zhang; Hanqiao Liu; Christopher Stevenson; Avrum Spira; Mary E Reid; Joshua D Campbell; Sarah A Mazzilli; Marc E Lenburg; Jennifer Beane
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 12.469

Review 7.  Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review.

Authors:  Asaf Maoz; Koji Matsuo; Marcia A Ciccone; Shinya Matsuzaki; Maximilian Klar; Lynda D Roman; Anil K Sood; David M Gershenson
Journal:  Cancers (Basel)       Date:  2020-05-29       Impact factor: 6.639

Review 8.  Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.

Authors:  Bilikis Aderonke Abolarinwa; Ridwan Babatunde Ibrahim; Yen-Hua Huang
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

Review 9.  Deregulation of HLA-I in cancer and its central importance for immunotherapy.

Authors:  Ahmet Hazini; Kerry Fisher; Len Seymour
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.